Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among HIV Infected Individuals Attending ART Centre at Pune: A Cross-Sectional Study

Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among HIV Infected Individuals Attending ART Centre at Pune: A Cross-Sectional Study

Blog Article

Background : We aimed to determine the anti-SARS-CoV-2 IgG antibodies among Planner people living with HIV (PLHIV) in Pune, India.Methods : This cross-sectional study was conducted between March 2021 and June 2021.Demographic and clinical information related to coronavirus disease 2019 (COVID-19) were recorded on structured questionnaires.Blood samples were collected and tested for anti-SARS-CoV-2 IgG antibodies using commercial ELISA.

Results : Of the 405 HIV infected individuals enrolled in the study, 223(55.1%) were females.Mean age and CD4 count of participants were 42 years (SD: 10) and 626 cells/mm 3 (SD: 284) respectively.A total of 382 (95%) PLHIV were virologically suppressed.

The seropositivity against SARS-CoV-2 was found in 221 PLHIV (54.6%, 95% CI: 49.7-59.4).

No significant association was found between demographic or clinical factors and seropositivity.Conclusion : A high prevalence of anti-SARS-CoV-2 IgG antibodies SIEMENS iQ700 LC91KWW69B - 90cm Wall-mounted cooker hood - Black Glass was found among PLHIV attending ART centre indicating an exposure to the virus among them.